DXCM Stock Overview
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally.
DexCom, Inc. Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||US$87.53|
|52 Week High||US$164.86|
|52 Week Low||US$66.89|
|1 Month Change||8.54%|
|3 Month Change||8.99%|
|1 Year Change||-30.75%|
|3 Year Change||100.79%|
|5 Year Change||363.74%|
|Change since IPO||2,882.28%|
Recent News & Updates
DexCom (NASDAQ:DXCM) Has A Pretty Healthy Balance Sheet
Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
|DXCM||US Medical Equipment||US Market|
Return vs Industry: DXCM underperformed the US Medical Equipment industry which returned -21.1% over the past year.
Return vs Market: DXCM underperformed the US Market which returned -9% over the past year.
|DXCM Average Weekly Movement||8.1%|
|Medical Equipment Industry Average Movement||9.5%|
|Market Average Movement||7.6%|
|10% most volatile stocks in US Market||17.1%|
|10% least volatile stocks in US Market||3.1%|
Stable Share Price: DXCM is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 8% a week.
Volatility Over Time: DXCM's weekly volatility (8%) has been stable over the past year.
About the Company
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM system for diabetes management; Dexcom Real-Time API, which enables invited third-party developers to integrate real-time CGM data into their digital health applications and devices; Dexcom ONE, that is designed to replace finger stick blood glucose testing for diabetes treatment decisions; and Dexcom Share, a remote monitoring system.
DexCom, Inc. Fundamentals Summary
|DXCM fundamental statistics|
Is DXCM overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|DXCM income statement (TTM)|
|Cost of Revenue||US$906.30m|
Last Reported Earnings
Jun 30, 2022
Next Earnings Date
|Earnings per share (EPS)||0.43|
|Net Profit Margin||6.28%|
How did DXCM perform over the long term?See historical performance and comparison